Midlife insulin resistance as a predictor for late-life cognitive function and cerebrovascular lesions
Manuscript Number:
19-0691R1
Author(s):
Laura L. Ekblad, Semi Helin, Saija Hurme, Jarkko Johansson, Antti Jula, Mira Karrasch, Juha Koikkalainen, Hanna Laine, Jyrki Lötjönen, Riitta Parkkola, Juha O. Rinne, Sini Toppala, Matti Viitanen
Disclosures
Laura L. Ekblad
Nothing to Disclose
Semi Helin
Nothing to Disclose
Saija Hurme
Nothing to Disclose
Jarkko Johansson
Nothing to Disclose
Antti Jula
Nothing to Disclose
Mira Karrasch
Nothing to Disclose
Juha Koikkalainen
Equity:
JK is a co-founder and shareholder at Combinostics Ltd.
Patents/Royalties
JK is an inventor of several patents hold by Combinostics Ltd but not related to this work.
Hanna Laine
Nothing to Disclose
Jyrki Lötjönen
Equity:
JL is a co-founder and shareholder at Combinostics Ltd
Lecture Fees:
JL has given educational presentations to Merck and Sanofi, paid to his institution.
Patents/Royalties
JL is an inventor of several patents hold by Combinostics Ltd but not related to this work.
Riitta Parkkola
Nothing to Disclose
Juha O. Rinne
Nothing to Disclose
Sini Toppala
Lecture Fees:
I have received a lecture fee of 400 euros once in 2018. I was invited to speak by Lundbeck.